Background. Healthcare claims are underutilized to identify factors associated with high outpatient antibiotic use. Methods. We evaluated ambulatory encounter claims of Medicaid-insured children in 34 Ohio counties in 2014. Rates of total antibiotic and azithromycin prescriptions dispensed were determined by county of patient residence. Standardized treatment rates by county were estimated for uncomplicated upper respiratory tract encounters (acute otitis media, pharyngitis, sinusitis, presumed viral infection) after adjusting for patient age and encounter provider type. Uncomplicated encounters included healthy children at initial presentation of illness. Adjusted odds of treatment were calculated for patient age, provider type, and county characteristics (rural vs metropolitan; poverty rate).
Reducing inappropriate antimicrobial use is critical to avoid future bacterial resistance, iatrogenic disease, and excess medical costs. The National Action Plan for Combating AntibioticResistant Bacteria has set the goal of reducing inappropriate antibiotic use in the outpatient setting by 50% by 2020 [1] . This goal is especially relevant to children for several reasons. First, children account for a large proportion of antibiotic consumption in the United States, with the highest rates of prescribing in children aged <3 years [2] . Second, data suggest that children may be most susceptible to changes in the normal microbiome [3] [4] [5] [6] [7] . Third, children will more likely suffer the consequences of antimicrobial resistance that results from societal and repeated personal exposure to antimicrobials as they reach adulthood [8] .
Previous estimates of outpatient antibiotic prescribing patterns in the United States provided valuable insight on a national scale [2, [9] [10] [11] [12] . However, those estimates are limited because they relied on provider surveys or pharmacy data that either do not capture all clinical settings/providers or are not linked to medical encounters. Conversely, healthcare claims include a variety of clinical settings and provider types and may be used by organizations charged with antimicrobial stewardship activities (eg, healthcare systems, health insurance companies). Partners for Kids (PFK) is a nonprofit, accountable care organization that accepts financial responsibility for approximately 330.000 Medicaid-insured children in a 34-county region of central and southeast Ohio [13] . The aim of this study was to determine whether healthcare claims can be used to identify potential targets for antimicrobial stewardship interventions. Specifically, we sought to evaluate the utility of claims data to (11) measure the prevalence and rates of outpatient antibiotic treatment in PFK children and (11) assess variability and identify the determinants of variability in antibiotic treatment rates for uncomplicated upper respiratory tract infections.
METHODS
PFK was established in 1994 and is governed by a board that includes representatives from Nationwide Children's Hospital (Columbus, Franklin County, Ohio) and primary and specialty practice groups that participate in the PFK provider network. Forty percent of enrolled children live in Franklin County, the most urban county in the PFK region, and the remainder reside throughout the 33 other counties, most of which are rural and many of which are Appalachian [13, 14] . This study was exempt from institutional review board review because it used de-identified, limited data to inform PFK quality improvement activities.
Overall Study Design
We used claims data for 2 separate retrospective observational analyses. First, the total volume and rates of outpatient antibiotic prescriptions dispensed to PFK children in 2014 were measured. We also measured azithromycin prescriptions specifically because prior studies have identified that it is commonly overused [9, 11] . Second, we evaluated all uncomplicated clinical encounters for infections of the upper respiratory tract (URT) in 2014 and assessed variability in treatment rates. In a subset of patients diagnosed with pharyngitis who received antibiotic treatment, we assessed use of streptococcal testing. Finally, concordance with guideline-recommended therapy for presumed bacterial infections was assessed.
Prevalence and Rates of Antibiotics Dispensed in 2014
Using 2014 claims data, we measured the number of enteral or parenteral (excluding topical and inhaled) antibiotic prescriptions dispensed by retail pharmacies to PFK members aged 0-18 years (Supplementary Table 1 lists the antibiotic classes included). We assumed that antibiotics were prescribed in the context of a medical encounter if claims identified an encounter ≤3 days before the antibiotic dispense date. From the healthcare claims we obtained patient age, county of residence, and prescriber type. Retail pharmacists provided the estimated days of therapy dispensed on pharmacy claims. We calculated rates of antibiotic prescriptions overall and for azithromycin specifically per person, per year of PFK membership (person-year). Children enroll in full calendar-month blocks, and PFK tracks the number of membership months. We considered each calendar month one-twelfth of a year for calculating rates.
Prescriber Type
Specialties were based on National Provider Identification numbers provided on the pharmacy claims. We grouped specialties into the following categories: physicians in emergency medicine, family medicine and/or pediatrics, nurse practitioners, physician assistants, and other provider types.
Encounters for the Infectious Upper Respiratory Tract Group of Diagnoses
We defined an infectious URT group of diagnoses that included both potential bacterial infections and presumed viral infections (Supplementary Table 2 ). We inferred the clinical diagnoses from the listed primary and secondary International Classification of Diseases, Ninth Revision (ICD-9) codes on the healthcare claim. Potential bacterial infections included acute otitis media, pharyngitis, and sinusitis. Presumed viral infections included acute upper respiratory infection, nasopharyngitis, laryngitis, and bronchitis, among others. Although pharyngitis may have a bacterial or viral etiology, we classified it as potentially bacterial because results of streptococcal testing may not have been available at the time of the encounter.
Uncomplicated Clinical Encounter Definition
To assess encounters for generally healthy children at initial presentation of illness, we excluded encounters in which the patient had codes indicating (11) complex/chronic medical conditions [15] ;64(11) concomitant bacterial infections or diagnoses outside the URT group (Supplementary Table 3) ;64(11) antibiotic treatment in the previous 30 days; or (11) another clinical encounter for an URT group diagnosis in the previous 30 days.
Associated Antibiotics Dispensed
We determined whether an antibiotic was dispensed ≤3 days following each clinical encounter, and if so, inferred the reason for antibiotic treatment from the coded diagnoses. When a claim included both potential bacterial and presumed viral diagnoses, the encounter was analyzed according to the potential bacterial diagnoses. If >1 URT group encounter occurred within 3 days prior to a dispensed antibiotic, the antibiotic was linked to the first encounter.
Encounter Provider Types
For all URT group encounters, the specialty of the medical provider was obtained from the healthcare claim submitted. Specialties were categorized as described above.
Multivariable Logistic Regression
To compare treatment rates for URT group encounters, we assessed multivariable logistic regression models. For each model, a dispensed antibiotic ≤3 days following the clinical encounter was the outcome, and patient age, prescriber type, and county characteristics were included as covariates. County characteristics included (11) the metropolitan vs rural area designation of the US Department of Health and Human Services' Office of Rural Health Policy [16] and (11) poverty rate (percentage of children aged <18 years living in poverty in 2014) from the US Census Bureau's Small Area Income and Poverty Estimates [17] . Counties with poverty rates greater than the median in our cohort (25%) were defined as high poverty.
Predictive margins for the outcome of dispensed antibiotics were used to calculate model-based direct standardized treatment rates with 95% confidence intervals (CIs) for each county, while accounting for patient age and provider type. Adjusted odds of treatment were calculated for patient age, provider type, and county characteristics. All analyses were conducted using Stata version 13 (StataCorp LP, College Station, Texas), R version 3.0.2 (R Foundation for Statistical Computing, Vienna, Austria), and SAS version 9.3 software (SAS Institute, Cary, North Carolina). Two-sided P values <.05 were considered statistically significant.
Diagnostic Appropriateness
Claims data allowed for examination of adherence to national clinical guidelines that recommend confirmation of group A Streptococcus in the posterior pharynx to diagnose streptococcal pharyngitis [18] . We assumed that antibiotic treatment dispensed ≤3 days after an encounter for pharyngitis, in the absence of concurrent bacterial diagnoses, was intended to treat streptococcal pharyngitis. We assessed for presence of a current procedural terminology (CPT) code for streptococcal confirmation (Supplementary Table 4 ).
Therapeutic Appropriateness
For URT group encounters with a dispensed antibiotic within 3 days, we determined whether the antibiotic represented firstline therapy recommended for the treatment of acute otitis media (amoxicillin) [19] , pharyngitis (penicillin or amoxicillin) [18] , and sinusitis (amoxicillin or amoxicillin-clavulanate) [20, 21] . We excluded 1.6% of encounters with >1 dispensed antibiotic because we could not determine from claims data which antibiotic was intended to treat the associated diagnosis. The duration of therapy and frequency of azithromycin treatment were also assessed. For the 6% of encounters with multiple potential bacterial diagnoses, we did not assess guideline-concordant therapy but did assess therapy duration and azithromycin use. Summary statistics included the χ 2 test (categorical variables) and analysis of variance (continuous variables).
RESULTS

Prevalence and Rates of Antibiotics Dispensed in 2014
Retail pharmacies dispensed 255 291 total antibiotic prescriptions to PFK members in 2014. Overall, >99% were enteral and >25% were dispensed to children aged <3 years. Amoxicillin was the most common antibiotic (40.9%), followed by azithromycin (16.3%), cefdinir (11.2%), amoxicillin-clavulanate (9.1%), and trimethoprim-sulfamethoxazole (6.9%). The mean duration of therapy dispensed was 9.7 days. The most common prescriber type was pediatricians (33.4%), followed by nurse practitioners (19.3%), family medicine physicians (15.5%), emergency medicine physicians (12.9%), and physician assistants (5.2%).
Rates of total antibiotic and azithromycin prescriptions were 800.4 (range, 530.4-1548.3; Figure 1A ) and 131.8 (range, 57.3-378.7; Figure 1B ) per 1000 person-years, respectively. Claims identified a medical encounter ≤3 days before the dispense date for 219 510 (86.0%) of prescriptions. Among 258 811 unique children who were PFK members for the entire year, 106 318 (41.1%) received at least 1 prescription in 2014.
Encounters for the Infectious Upper Respiratory Tract Group of Diagnoses
Among 398 217 encounters in the URT diagnostic group in 2014, 246 866 met inclusion criteria (Figure 2 ). The median patient age was 5 years (interquartile range, 2-10 years). Pediatricians were the most common provider type (36.0%), followed by family medicine physicians (11.1%) and nurse practitioners (8.1%). For 29.5% of the encounters, the healthcare claim listed only a facility identification number, thus the specific provider type could not be determined; 87% of these encounters occurred in an emergency department setting. Children residing in rural counties and high-poverty counties accounted for 105 184 (42.6%) and 101 502 (41.1%) encounters, respectively. At least 1 antibiotic was dispensed within 3 days of 113 823 (46.1%) URT group encounters. The majority (86%) were dispensed on the same date as the encounter (Supplementary Figure 1) . Of 107 127 (43.4% of URT group) encounters for presumed viral infection alone, 21 093 (19.7%) were associated with antibiotic treatment, which accounted for 18.5% of all prescriptions for URT group encounters. Crude treatment rates among the 34 PFK counties ranged from 36.7% to 62.5% (Supplementary Figure 2) . As a proportion of total URT group encounters in each county, antibiotic treatment for presumed viral infection alone ranged from 4.8% to 16.6%, and treatment for sinusitis (without other potential bacterial diagnoses) ranged from 2.2% to 22.0%.
Multivariable Logistic Regression
Complete and valid information for all variables in the analysis was available for 246 812 (>99.9%) of URT group encounters (Supplementary Table 5 ). Figure 3 displays the standardized treatment rates by county after adjusting for patient age and provider type, which ranged from 35.9% (95% CI, 33.3%-38.5%) to 63.2% (95% CI, 61.5%-64.9%). Supplementary Table 6 lists the number of patient encounters, median age at encounter, percentage of children in poverty, crude treatment rate, and standardized treatment rate for each county. Older children were more likely to receive antibiotics than younger children (Table 1) . After adjusting for patient age and county characteristics, the provider type with the highest odds ratio of antibiotic treatment when compared to pediatricians was family medicine physicians, followed by physician assistants and nurse practitioners. Living in a rural or high-poverty county each increased the odds of antibiotic treatment by 30% after adjusting for patient age and provider type.
Diagnostic Appropriateness
Among 31 373 encounters for pharyngitis with associated antibiotic treatment, 13 091 (41.7%) did not include a CPT code for a test to confirm group A streptococcal infection. Table 2 describes the use of guideline-concordant therapy and azithromycin, as well as median duration of therapy, for the 112 028 URT group encounters with a single associated dispensed antibiotic. Of the presumed bacterial infections, acute otitis media was most common. Excluding encounters with multiple potential bacterial diagnoses, 49 406 of 105 300 (46.9%) prescriptions were guideline-discordant. Assuming that 90% of patients had no reported penicillin allergy [22] , we estimate that 42.2% of treatment was inappropriate among this group of diagnoses. The diagnosis of sinusitis alone was less commonly associated with guideline-concordant therapy and more commonly associated with azithromycin treatment. Presumed viral infections accounted for nearly one-fifth of the total dispensed antibiotics for URT group encounters, and nearly half were treated with azithromycin.
DISCUSSION
We found that healthcare claims data were a valuable repository from which to glean antibiotic dispensation patterns in a large pediatric Medicaid population from a wide geographic area. The prevalence analysis was useful to document the total volume and rates of antibiotics dispensed in 2014, while the URT group analysis included specific encounter data and revealed patient, provider, and county variables associated with antibiotic treatment. Both analyses inform antimicrobial stewardship efforts. We found that >25% of the total antibiotics were dispensed to younger children (<3 years), but the odds of antibiotic treatment for URT illnesses were increased for older children. Similarly, pediatricians accounted for the greatest volume of antibiotic prescriptions in this cohort, but family medicine physicians, physician assistants, and nurse practitioners were more likely to treat URT illnesses. In addition, in the URT group analysis, we identified that patient residence in a rural or high-poverty county increased the odds of receiving antibiotics. We also estimated that 42% of antibiotics dispensed to children with URT illnesses were inappropriate, either because they were associated with a presumed viral infection alone or because of an inappropriate choice of antibiotic. Finally, both analyses suggest that azithromycin is an important target for stewardship, particularly as an inappropriate treatment for sinusitis and viral infections. Claims data may supplement other methodologies that define antibiotic use patterns in children. Data on the prevalence of antibiotic prescribing in children have previously been based on a national retail pharmacy database [9] , cross-sectional surveys [2, [10] [11] [12] , or networks of clinics with integrated electronic medical record systems [23, 24] . Although these methods provide valuable information for antimicrobial stewardship, they all have limitations. National pharmacy database information is not linked with medical encounters, limiting inferences about the reasons for prescribing. The National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey include both diagnoses and therapies for medical encounters but do not capture urgent care/retail clinic data and may underrepresent nurse practitioner and/or physician assistant prescribing. The lack of integrated electronic medical record networks in many areas limits the use of this tool to analyze prescribing over wide geographic areas. In contrast, claims data allow a comprehensive assessment of provider types and clinical settings, including those settings that lack an integrated electronic medical record system. In addition, claims data reflect antibiotics dispensed rather than prescribed, which may be a more accurate indication of antibiotic consumption.
Recently, the Centers for Disease Control and Prevention (CDC) published 4 core elements of outpatient antimicrobial stewardship: commitment; action for policy and practice; tracking and reporting; and education and expertise [25] . In this study, we demonstrated the feasibility of using healthcare claims data to track antibiotic prescribing patterns within an accountable care organization. Although our study assessed medical providers on a broad scale, similar methodology could be used to track prescribing patterns of individual medical practices or providers. Individual data could be used for feedback and peer comparison, which has been considered key to reducing unnecessary antibiotics in pediatric and adult primary care settings [23, 26] . Healthcare claims may be one of the only methods to obtain data about antibiotic prescribing practices for small or independent clinics. Any entity with access to healthcare claims, including commercial insurance plans or Medicare, could potentially perform similar analyses and greatly expand antibiotic stewardship into resource-limited and/or rural counties.
CDC also recommends identification of high-priority conditions for tracking and reporting [25] . Partners for Kids has previously examined Healthcare Effectiveness Data and Information Set measures, including the avoidance of antibiotics for uncomplicated viral upper respiratory infections [14] . However, as CDC and published literature highlight, clinicians may manipulate diagnostic codes (diagnosis shifting) to justify antibiotic prescribing [25, 27] . In our cohort, variability in treatment rates for presumed viral infections and sinusitis suggests the possibility of diagnosis shifting. For example, in 4 counties (Coshocton, Fayette, Morrow, Muskingum), antibiotic treatment was provided for viral infections >3 times as often as for sinusitis, whereas in Noble county the ratio was opposite (Supplementary Figure 1) . To mitigate this problem, we chose to measure the overall percentage of antibiotics dispensed within an URT group of diagnoses because if diagnosis shifting occurs, it is unlikely that a code outside the URT group would be applied.
We recognize several limitations of using claims data to identify stewardship targets. We were unable to review the complete medical record, limiting data regarding patient race, medication allergies, and provider type for some encounters. We assumed that an encounter preceding antibiotic dispensation indicated the reason for antibiotic treatment, but multiple encounters and/or phone prescribing within the 3-day period may confound the data. The duration of antibiotic therapy was provided on the healthcare claim by retail pharmacists without standardized methodology. Finally, the population was regional and homogeneous in their socioeconomic status, even though they ranged from inner city to Appalachian rural. Our findings may not be generalizable to all children because parents of Medicaid-insured children have been previously found to be more likely to request antibiotics from providers [28] . Despite these limitations, the stewardship opportunities identified in this study were consistent with previously published findings, such as antibiotic use in young children and in those from economically disadvantaged areas [9] , treatment of streptococcal pharyngitis without confirmatory testing [2] , deviation from guideline-recommended therapy for common respiratory conditions [12] , and overuse of azithromycin [11, 12] .
In conclusion, we demonstrated the feasibility of using healthcare claims data to define outpatient antibiotic prescribing patterns and assess determinants of variability among Medicaid-insured children. Our data suggest that efforts to decrease pediatric antibiotic use should focus on prescriptions provided to young children, rural and high-poverty counties, prescribing of azithromycin, and all practitioners including nonphysicians. Claims data present a promising strategy to track and report prescribing patterns among large numbers of clinicians. Rates of antibiotic treatment for groups of related diagnoses, such as URT infections, may mitigate the problem of diagnosis shifting and may be optimal quality measures for provider feedback and peer comparison.
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